This week's Medtech in a Minute features news about Boston Scientific and a potentially dangerous chemical used in IV bags ...

Click Therapeutics’ CEO discusses the first FDA-cleared depression app, migraine treatment breakthrough, and digital ...

Industry consultant Michael Drues will discuss how medical device companies can better prepare for FDA inspections.

North Carolina becomes the second state to ban DEHP in medical devices, requiring IV bag manufacturers to phase out usage by 2030.

Torrington, CT-based Dymax will exhibit at MD&M West 2026, taking place February 3-5, at the Anaheim Convention Center in ...

Hellman & Friedman is reportedly looking to sell the drug-eluting stent pioneer for about $9 billion, according to a report ...

Augurex CEO Neil Klompas discusses goals for the company in this clip from the latest episode of Let’s Talk Medtech.

Boston Scientific has agreed to acquire Penumbra in a deal worth about $14.5 billion. Boston Scientific has agreed to acquire ...

Medtronic CEO Geoff Martha shed some light on the company's M&A strategy this week at the J.P. Morgan Healthcare Conference.

Elixir Medical's DynamX Bioadaptor restores natural artery function, reducing the risk of future cardiac events.

Launched in 2021, Boston-based Eyebot places its vision testing technology in popular sites like schools, grocery stores, and ...

While still a couple of years out, MD+DI gained some insights into Dexcom's next-generation sensor from an interview with the ...